Join us in Boston!
November 2-4, 2011

Thank you to all of our speakers, sponsors, and exhibitors for your support and contribution, and to all the delegates for your participation.
The success of this event is largely due to the dedicated participants that return with us year after year.

If you would like to share your feedback, or give input for next year’s event, please contact Margit Eder at

Discovery on Target 2010

Concurrent Tracks | November 2-3, 2010 

HDAC Inhibitors

GPCR-Based Drug Discovery

Ion Channels as Therapeutic Targets

Targeting the P13K Pathway 

Concurrent Tracks | November 3-4, 2010 

RNAi for Functional Screens
The Challenge of Developing Kinase Inhibitors
Diabetes Drug Discovery
New Ways to Tackle COPD and Other Chronic Pulmonary Diseases 



Allosteric Modulators of GPCRs  

Structure-Based Design of Ion Channel – Linked Receptors   

Best Practices for Setting Up Effective RNAi Screens  

In vivo Discovery and Validation Using RNAi  

Assessing Cardio Safety of Diabetes Drug Candidates  

*Separate registration required. 


Edward Seto, Ph.D. 

Chairman, Department of Molecular Oncology, H. Lee Moffitt Cancer Center 

Gregory J. Kaczorowski, Ph.D. 

Adjunct Professor, Physiology and Pharmacology, New Jersey Medical School; Adjunct Professor, Physiology and Biophysics, Robert Wood Johnson Medical School 

Laszlo Kiss, Ph.D. 

Senior Research Fellow, Merck Research Laboratories 

Spyro Mousses, Ph.D. 

Vice President, Office of Innovation and Director, Center of BioIntelligence, Translational Genomics Research Institute 

Jorge Plutzky, M.D. 

Director, The Vascular Disease Prevention Program, Cardiovascular Division, Brigham and Women’s Hospital and Associate Professor, Harvard Medical School 

Thomas Sakmar, M.D. 

Professor, Molecular Biology and Biochemistry, Rockefeller University 




Arrow Overshort courses




The exhibit hall was sold out in 2015, so please contact us early to reserve your place. To customize your sponsorship or exhibit package for 2016, contact:

Jon Stroup
Sr. Business Development Manager



2015 Tracks

September 21

Next-Generation Histone Deacetylase Inhibitors Symposia

Strategies for Rare Diseases Symposia

September 22

Developing CRISPR-Based Therapies Symposia

September 22 - 23

Targeting Epigenetic Readers and Chromatin Remodelers

Targeting the Ubiquitin Proteasome System

Targeting the Microbiome

GPCR - Based Drug Discovery - Part 1

Antibodies Against Membrane Protein Targets - Part 1

RNAi for Functional Genomics Screening

Gene Therapy Breakthroughs

Targeting Ocular Disorders

September 23 - 24

Targeting Histone Methyltransferases and Demethylases

Targeting the Unfolded Protein Response

Kinase Inhibitor Discovery

GPCR-Based Drug Discovery - Part 2

Antibodies Against Membrane Protein Targets - Part 2

New Frontiers in Gene Editing

Quantitative Systems Pharmacology

2015 Short Courses

SC1: Cancer Metabolism: Pathways, Targets and Clinical Updates

SC2: Leveraging Data and Analytics for Drug DiSCovery

SC3: Setting Up Effective Rnai SCreens: From Design to Data to Validation

SC4: Phenotypic SCreening and Chemical Probe Development

SC5: GPCR Structure-based Drug Discovery

SC6: Targeting of GPCRs with Monoclonal Antibodies

SC7: Setting Up Effective Functional SCreens Using 3D Cell Cultures

SC8: Targeting Protein-protein Interactions: Biophysical Approaches

SC9: Preclinical Animal Models for Ocular Indications

SC10: Introduction to Allosteric Modulators and Biased Ligands of GPCRs

SC11: Introduction to Targeted Covalent Inhibitors

SC12: Assays and High-throughput SCreening for Novel Epigenetic Inhibitors

SC13: Gamification and Drug Target Challenges

SC14: A Primer to Gene Editing: Tools and Applications

SC15: Using Mechanistic Physiological Models In Drug Development